𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients

✍ Scribed by A. Humar; Y. Lebranchu; F. Vincenti; E. A. Blumberg; J. D. Punch; A. P. Limaye; D. Abramowicz; A. G. Jardine; A. T. Voulgari; J. Ives; I. A. Hauser; P. Peeters

Book ID
114805546
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
382 KB
Volume
10
Category
Article
ISSN
1600-6135

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Increased incidence of cytomegalovirus i
Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis
✍ Kevin T. Shiley; Leanne B. Gasink; Todd D. Barton; Patrice Pfeiffenberger; Kim M πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 1 views

Optimal measures for the prevention of cytomegalovirus (CMV) in high-risk orthotopic liver transplant (OLT) patients are unknown. The charts of high-risk OLT recipients with 12 months of follow-up who were transplanted over a 44-month period were reviewed. The incidence of CMV disease in CMV-seropos